Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pure Lip

This article was originally published in The Tan Sheet

Executive Summary

Pure Lip Prevention, promoted as "the first all natural, nonprescription lip care ointment specifically designed to prevent the outbreak of cold sores," debuted online in September with a giveaway of more than 10,000 free trial tubes during a four-day period. Los Angeles-based Pure Lip's first product, the clear, hypoallergenic ointment is packaged in a 5.5 g extended-tip tube and is sold exclusively over the Internet for $10.95. Prevention includes a "triple defense system" of moisture, maintenance and ViraZinc, which provides a steady release of zinc before cold sore virus symptoms appear, packaging states. Ingredients include white petrolatum, zinc glycerolate, meadowfoam seed oil, green tea extract, vitamins C and E, grapeseed extract, coenzyme Q10 and stearyl glycyrrhetinate. Packaging carries the FDA disclaimer required under DSHEA for supplement products. Pure Lip hopes to introduce two new lip products for extreme weather exposure and cold sore treatment in early 2000. The company has media deals with several health-related Internet companies and plans to examine offline promotion to doctors and dentists

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS090453

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel